Assignee
IMARA INC
US·1 granted patent·5 pending applications·2 citations·filing 2017–2021
Top patents by PatentIndex Score
6 records- 0173US11370795B2Process for the synthesis of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-oneIMARA INC·Filed 2018·Granted Jun 28, 2022·2 cites·9 claims
- 0252US2021085684A1Pde9 inhibitors for treatment of peripheral diseasesIMARA INC·Filed 2020·Application pending·0 cites
- 0350US2022023302A1Pde9 inhibitors for treating sickle cell diseaseIMARA INC·Filed 2021·Application pending·0 cites
- 0444US2022000824A1Treatment of pulmonary arterial hypertension using therapeutically effective oral doses of 10-nitro-9(e)-octadec-9-enoic acidIMARA INC·Filed 2021·Application pending·0 cites
- 0541US2019307754A1Pde9 inhibitors for treatment of peripheral diseasesIMARA INC·Filed 2017·Application pending·0 cites
- 0636US2022047589A1Pde9 inhibitors for treating thalassemiaIMARA INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMARA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →